Semax Tracker App
Track Your Semax Research Notes
Semax is a synthetic ACTH(4-10) analog with limited human evidence and more published work in animal and cellular models. Shotlee helps you log the exact protocol you are following so you can review it later.
What Is Semax?
Semax is a synthetic ACTH(4-10) analog. The published literature is much stronger in preclinical and translational models than in large human trials, so it is best treated as an investigational compound.
Shotlee tracks every aspect of your protocol: route, timing, dose, side effects, sleep, focus notes, and any objective metrics you want to follow. Clean logs make it easier to review what actually happened.
What to Track in Shotlee
Build a complete Semax protocol record from day one.
How to Track Your Semax Protocol
Semax Key Facts
Protocol FAQs
Log each injection in Shotlee with the dose, date, injection site, and any side effects. Shotlee keeps a complete timeline of your Semax protocol.
Yes. Shotlee supports tracking multiple medications and peptides simultaneously, including combination protocols.
Record every dose, injection site, timing, any side effects, and weekly weight/measurements. This data helps you and your prescriber optimize your protocol.
Yes. Shotlee is completely free for dose logging, side effect tracking, and protocol management. No hidden fees.
Open the Shotlee app, navigate to the dose logging screen, select Semax, and enter the dose amount, route, timing, and notes.
Track headaches, nasal irritation if using intranasal administration, sleep changes, mood changes, and any unusual symptoms.
There is no standardized human response timeline, so tracking your own repeated measures is more useful than assuming a fixed result window.
Track Your Semax Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semax
RFK Jr.'s Peptide Policy Could Boost Hims & Hers GLP-1 Shift
Shares of Hims & Hers surged after HHS Secretary RFK Jr. revealed FDA plans to review peptides for compounding under the 503A bulk list. This comes as the telehealth leader evolves its high-margin compounded GLP-1 business toward branded options and new peptide therapies. CEO Andrew Dudum and CMO Dr. Patrick Carroll highlight the potential for regulated, physician-led peptide access.
6 min read
Semax: Potential of a Synthetic Peptide in Neuroscience Research
Semax, a synthetic heptapeptide derived from ACTH research, is capturing interest for its neuroactive properties without endocrine effects. Ongoing studies highlight its roles in neuroplasticity, stress resilience, and cognitive function. This guide delves into the science behind its multifaceted research potential.
5 min read
Semax Peptide: Research on Neuroprotection, Inflammation, and Vascular Effects
Semax, a synthetic heptapeptide, has demonstrated neuroregulatory, neuroprotective, and immunomodulating properties in various research models. This article examines its biochemical characteristics, possible effects on gene expression, interactions with neurotransmitter systems, vascular modulation, metal binding, and utility in ischemia-reperfusion injury studies.
5 min read